• Contact us
Menu
  • Contact us
  • English
Search
Close
Peter Marks

Old keyword: Peter Marks

Critical need for harmonized post marketing surveillance in gene therapy | Virtual Summit 2020

With regulatory approval of the first gene therapy product expected, there is an urgent need for a mechanism to collect long-term data on safety and variability and durability of efficacy. There will be elements required by regulators for post marketing surveillance and additional data needed to enhance our understanding of gene therapy outcomes and their […]

ELEARNING CENTRES
Inherited bleeding disorders
Hemophilia
Women and girls with hemophilia
von Willebrand disease
Rare clotting factor deficiencies
Inherited platelet disorders
Non-factor replacement therapy
Gene therapy
Prophylaxis
Inhibitors
Clinical trials
GUIDELINES
Hemophilia Guidelines
Hemophilia Guidelines Resource Hub
VWD Guidelines
KEY EDUCATIONAL RESOURCES
Hemophilia in Pictures
Laboratory Manual
Assessment tools
Online CFC registry
In-HemoAction Card Game
eLearning Modules
CONTACT US
World Federation of Hemophilia
1425, boul. René Levesque Ouest
Bureau 1200
Montréal, Québec H3G 1T7 Canada
Tel.: +1 (514) 875-7944
Fax.: +1 (514) 875-8916
Email: [email protected]
WFH online contact form>
STAY CONNECTED!
  • Subscribe now
Twitter Linkedin Facebook Youtube
  • Disclaimer
  • Privacy policy
  • Fraud alert
  • Contact us
Français / Español / 简体中文 / русский / العربية / 日本語
© 2023 World Federation of Hemophilia